Since the ‘Curapel Project’ won ‘Biomedical Project of the Year’ in 2008 and the Curapel company was spun out of the University of Manchester, the company has been growing year on year. Curapel is committed to the process of scientifically and clinically validated product development to satisfy unmet clinical need in chronic skin diseases such as eczema and psoriasis, disorders of skin pigmentation, supporting the skin microbiome, the gut-skin axis and improving transdermal delivery technology. Products in these areas are being developed with the protection of a robust portfolio of patents granted to Curapel.